These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 374171)

  • 1. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M; Kawamori R; Abe H
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell.
    Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H
    Diabetes; 1980 Sep; 29(9):762-5. PubMed ID: 7002690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
    Ross SA; Brown JC; Dupré J
    Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man.
    Hanna AK; Zinman B; Nakhooda AF; Minuk HL; Stokes EF; Albisser AM; Leibel BS; Marliss EB
    Metabolism; 1980 Apr; 29(4):321-32. PubMed ID: 6990172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
    Ross SA; Dupre J
    Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T; Raskin P; Aydin I; Unger R
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis.
    O'Brien TD; Hayden DW; Johnson KH; Stevens JB
    Vet Pathol; 1985 May; 22(3):250-61. PubMed ID: 3890345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and glucagon secretion in diabetic and non-diabetic patients with circulating islet cell antibodies.
    Tiengo A; Del Prete GF; Nosadini R; Betterle C; Garotti C; Bersani G
    Diabetologia; 1977 Sep; 13(5):451-8. PubMed ID: 332569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of the blunted glucagon response to insulin-induced hypoglycemia in diabetics].
    Katsura M
    Nihon Naibunpi Gakkai Zasshi; 1986 Nov; 62(11):1276-88. PubMed ID: 3542595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
    Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
    Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 'artificial beta cell' for control of diabetes mellitus: effect on plasma glucagon levels.
    Horwitz DL; Gonen B; Jaspan JB; Langer BG; Rodman D; Zeidler A
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):639-44. PubMed ID: 394885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The response of pancreatic alpha and beta cells to oral glucose stimulation in subjects with risk of diabetes].
    Ferrero E; Casale G; Ravecca D; Ricci C
    Minerva Med; 1981 Apr; 72(17):1065-70. PubMed ID: 6112718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon and carbohydrate disorder in a totally pancreatectomized man (a study with the aid of an artificial endocrine pancreas).
    Santeusanio F; Massi-Benedetti M; Angeletti G; Calabrese G; Bueti A; Brunetti P
    J Endocrinol Invest; 1981; 4(1):93-6. PubMed ID: 7016969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I; Vigas M; Jurcovicová J; Repceková D; Kolesár P
    Diabetes; 1978 Apr; 27(4):396-9. PubMed ID: 640244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegaly: insensitivity of the pancreatic alpha cell to hyperglycaemia.
    Seino Y; Taminato T; Goto Y; Inoue Y; Kadowaki S; Mori K; Imura H
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):577-81. PubMed ID: 371862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insuppressibility of plasma glucagon by orally or intravenously administered glucose in diabetes mellitus.
    Kurahachi H; Seino Y; Ikeda M; Sakurai H; Yoshimi T; Imura H
    Endocrinol Jpn; 1977 Oct; 24(5):413-9. PubMed ID: 590199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance.
    Borghi VC; Wajchenberg BL; Cesar FP
    Metabolism; 1984 Dec; 33(12):1068-74. PubMed ID: 6390086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.